Gould Asset Management’s Immunogen Inc IMGN Stock Holding History

Gould Asset Management’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-15,000	Closed	-$54K	–	146
2020 Q3	$54K	Hold	15,000	–	–	0.02%	135
2020 Q2	$69K	Hold	15,000	–	–	0.02%	132
2020 Q1	$51K	Hold	15,000	–	–	0.02%	125
2019 Q4	$77K	Hold	15,000	–	–	0.03%	146
2019 Q3	$36K	Hold	15,000	–	–	0.01%	142
2019 Q2	$33K	Hold	15,000	–	–	0.01%	143
2019 Q1	$41K	Hold	15,000	–	–	0.02%	136
2018 Q4	$72K	Hold	15,000	–	–	0.03%	125
2018 Q3	$142K	Hold	15,000	–	–	0.06%	140
2018 Q2	$146K	Hold	15,000	–	–	0.06%	135
2018 Q1	$158K	Hold	15,000	–	–	0.07%	139
2017 Q4	$96K	Hold	15,000	–	–	0.04%	138
2017 Q3	$115K	Hold	15,000	–	–	0.05%	135
2017 Q2	$107K	Buy	+15,000	New	+$68.6K	0.05%	126

Other funds holding IMGN

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Gould Asset Management's IMGN Position: Q4 2020 in Review

Gould Asset Management sold out of Immunogen Inc (IMGN) in Q4 2020, closing a stake of 15,000 shares — an estimated $54K sold.

Gould Asset Management first reported a position in IMGN in Q2 2017 and held it in 14 quarters. The position peaked at $158K in Q1 2018. 211 funds tracked by Wall St. Rank hold IMGN as of Q4 2020.

Gould Asset Management reported no remaining Immunogen Inc position as of Q4 2020 after selling out during the quarter.
Gould Asset Management sold 15,000 Immunogen Inc shares in Q4 2020, an estimated $54K.
Gould Asset Management first reported a position in Immunogen Inc in Q2 2017 and held it in 14 quarters.
Gould Asset Management's Immunogen Inc position peaked at $158K in Q1 2018.
211 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2020.

Based on Gould Asset Management's 13F filing for Q4 2020, filed 2 Feb 2021.